ixlayer

ixlayer is a health technology company that provides a cloud-based platform for diagnostic laboratory testing. Founded in 2018, ixlayer initially focused on remote lab testing for Alzheimer's patients but expanded to offer white-labeled, at-home, and on-site health tests. The company's platform connects the entire ecosystem of diagnostic services, enabling healthcare organizations to deploy at-home testing initiatives quickly and easily. ixlayer's solution covers diagnostic kits, diagnostic lab testing services, and reporting of results. It also offers digital tools for patient education, contextualized lab results, remote program monitoring, and personalized calls to action for medication adherence protocols and diagnostic testing regimens.

ixlayer's platform powers diagnostic tests annually and serves as the backbone for thousands of health testing programs. The company's tests are processed in independent, CLIA-certified labs and cover a wide range of health areas, including men's and women's wellness, sexually transmitted diseases, and chronic condition management. 

The company has experienced significant growth, with a 100% increase in YoY revenue growth reported in August 2023, leading to its inclusion in the Inc. 5000 list of fastest-growing private companies in America.

Key customers and partnerships

As of August 2024, the company had facilitated over 1,100 nationwide programs and enabled over 4 million patient care journeys. 

Ixlayer’s notable customers include the US Coast Guard, Stanford Health, Salesforce, and multiple national health plans.

In January 2024, ixlayer joined the Innovators' Network at the American Heart Association Center for Health Technology & Innovation, furthering its mission to increase access to at-home diagnostic testing, particularly in cardiovascular health. This partnership allows ixlayer to leverage the Association's digital guidelines and best-in-class science to develop innovative digital healthcare technologies.

In March 2023, the company formed a partnership with Curavit Clinical Research and Medable, Inc. to support decentralized clinical trials. The collaborations aimed to improve patient engagement, treatment selection, and persistence in clinical research and drug therapies.

In February 2023, ixlayer joined the BrightInsight Ecosystem, partnering to integrate diagnostic testing into drug companion apps. 

In October 2022, ixlayer became the platform for CVS Health home tests, initially offering kits for vitamin D, Lyme disease, sexually transmitted infections, and thyroid function.